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CI = confidence interval; CPI = culture-positive infection; FiO2 = fractional inspired oxygen; MOF = multiple organ failure; PaO2 = arterial oxygen
tension; SICU = surgical intensive care unit; WBC = white blood cell.
Abstract
Introduction Our primary objective was to determine the impact of traumatic injury, onset of infection,
organ/metabolic dysfunction, and mortality on serum cholesterol.
Methods During 676 surgical intensive care unit (SICU) days, 28 ventilated trauma patients underwent
daily measurement of white blood cell (WBC) count and differential, cholesterol, arterial oxygen
tension/fractional inspired oxygen, bilirubin, glucose, creatinine, and bicarbonate. With the onset of
infection, WBC response was considered positive if the WBC count was 16.0 or greater, immature
neutrophils were 10% or greater, or WBC count increased by 20%. Cholesterol response was
considered positive if cholesterol decreased or failed to increase by 10%.
Results Injury Severity Score was 30.6±8.6 and there were 48 infections. Initial cholesterol was
decreased (119±44mg/dl) compared with expected values from a database (201±17mg/dl;
P<0.0001). The 25 survivors had higher cholesterol at SICU discharge (143±35mg/dl) relative to
admission (112±37 mg/dl; P<0.0001). In the three patients who died, the admission cholesterol was
175±62mg/dl and the cholesterol at death was 117±27 mg/dl. The change in percentage of
expected cholesterol (observed value divided by expected value) from admission to discharge was
different for patients surviving (16±19%) and dying (–29±19%; P=0.0005). With onset of infection,
the WBC response was positive in 61% and cholesterol response was positive in 91% (P=0.001).
Percentage of expected cholesterol was decreased with each system dysfunction: arterial oxygen
tension/fractional inspired oxygen <350, creatinine >2.0mg/dl, glucose >120mg/dl, bilirubin
>2.5mg/dl, and bicarbonate ≥28 or ≤23 (P<0.01). Percentage of expected cholesterol decreased
as the number of dysfunctions increased (P=0.0001).
Conclusion Hypocholesterolemia is seen following severe injury. Convalescing patients (ready for
SICU discharge) have improved cholesterol levels, whereas dying patients appear to have progressive
hypocholesterolemia. Decreasing or fixed cholesterol levels suggest the development of infection or
organ/metabolic dysfunction. Cholesterol responses are more sensitive for the onset of infection than
are WBC responses. Sequential cholesterol monitoring is recommended for patients with severe
trauma.
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Introduction
In 1994 Dunham and coworkers [1] demonstrated that
patients with severe trauma had a sudden reduction in total
serum cholesterol concentration. Hypocholesterolemia has
been found in patients undergoing surgical interventions [2],
and in those with multiple organ dysfunction syndrome [3–5]
and burns [6]. There is also a suggestion that serum choles-
terol correlates with organ failure and sepsis [1]. However,
the use of serum cholesterol as a prognostic indicator of
infection and multiple organ dysfunction syndrome, and as a
biologic marker for resolution of systemic inflammation is less
well defined. Proposed explanations for the development of
hypocholesterolemia include downregulation of hepatic syn-
thesis [5], dilutional effects with resuscitation [7], loss of
apoproteins in burns after blister formation [6], and metabolic
utilization [5,8].
Hypocholesterolemia occurring with the development of
infection was demonstrated during the 15-year period of the
Kaiser Permanente study, conducted in 15000 healthy men
and women [9]. Other authors have associated hypocholes-
terolemia with inflammatory states [10,11]. A 30% or greater
reduction in lipid and lipoprotein concentrations is known to
occur in a variety of inflammatory states [11]. Interleukin-6
and tumor necrosis factor-α have been implicated as potent
negative regulators of lipoprotein metabolism in vitro [12,13]
and in vivo [14,15].
Fraunberger and coworkers [13] demonstrated a relationship
between hypocholesterolemia and several disease states, as
well as organ dysfunction. In patients with multiple organ dys-
function syndrome, a plasma cholesterol below 100mg/dl
was associated with increased mortality (P<0.05). A
decrease in plasma cholesterol was also associated with
increased circulating levels of tumor necrosis factor.
The stimuli for the present study were our previous experi-
ence and the evolving literature. This study assessed four
hypotheses: hypocholesterolemia is seen early after severe
injury; hypocholesterolemia is improved at surgical intensive
care unit (SICU) discharge in surviving patients as compared
with cholesterol levels at admission; with the onset of infec-
tions, hypocholesterolemia is persistent or progressive; and
hypocholesterolemia is associated with organ/metabolic dys-
function.
Methods
Patients/design
The Institutional Review Board for Investigation of Human
Subjects approved this study.
All patients admitted to the trauma service at Saint Elizabeth
Health Center in Youngstown, Ohio (a level I trauma center;
under the care of CMD) had total serum cholesterol (choles-
terol) measured as part of their routine morning laboratory
evaluation. Between November 2000 and October 2002,
28 acutely injured patients with either blunt or penetrating
traumatic injuries requiring 7 days or more of mechanical ven-
tilation were studied. Data were collected during 676 con-
secutive days of SICU stay. Laboratory data were analyzed
with a specific focus on cholesterol values and their relation
to traumatic injury, onset of culture-positive infection (CPI),
organ/metabolic dysfunction, and SICU discharge.
Laboratory data
Laboratory values that were monitored included white blood
cell (WBC) count, WBC differential, cholesterol, arterial
oxygen tension (PaO2)/fractional inspired oxygen (FiO2), total
bilirubin, serum creatinine, serum bicarbonate, and serum
glucose. The percentage of immature neutrophils was the
sum of the percentage of bands, myelocytes, and metamyelo-
cytes. Expected cholesterol values were based on compre-
hensive age- and sex-specific data from the general
population [16]. SICU admission (postinjury) cholesterol was
defined as the mean of morning cholesterol values on hospi-
tal days 1, 2, and 3. It seemed that a mean value from the first
3 days, rather than a single-day point estimate, would more
likely reflect the postinjury cholesterol response. During the
SICU stay a mean cholesterol value was computed. SICU
discharge cholesterol was defined as the mean of morning
cholesterol values on the last 3 days of the SICU stay. The
percentage of expected cholesterol was computed as the
measured serum cholesterol divided by the expected choles-
terol.
Culture-positive infection
CPI was defined as an SICU day in which there was clinical
evidence for a new infection: two or more criteria for systemic
inflammatory response syndrome met; bacterial growth on a
culture medium; and need for antimicrobial therapy (initiated,
modified, or continued). With the exception of bacteremia
and vascular catheter infections, a CPI required the presence
of polymorphonuclear neutrophils on Gram stain or cell analy-
sis at the infection site. Vascular catheter infections had 100
bacterial colonies or more on semiquantitative culture. A diag-
nosis of pneumonia required moderate to abundant polymor-
phonuclear leukocytes on sputum Gram stain, moderate to
abundant bacterial growth on culture medium, a decreasing
PaO2/FiO2, and a new or progressive pulmonary infiltrate on
chest X-ray film.
White blood cell response and cholesterol response
at the time of a culture-positive infection
Because infections typically evolve over a couple of days, a
mean of WBC and cholesterol values before CPI and at the
time of CPI were used, as opposed to using single-day point
estimates. The WBC count, percentage of immature neu-
trophils, and cholesterol before a CPI were computed. These
values were the means of the laboratory data for the 2 days
before a CPI. The WBC count, percentage of immature neu-
trophils, and cholesterol at the time of a CPI were also com-
puted. These values were the means of the laboratory data onR147
the day of a CPI and the day after a CPI. Before analyzing the
WBC and cholesterol responses, we stipulated WBC and
cholesterol changes or values that were thought to provide a
clinical indication that an infection might have developed. The
following a priori criteria were applied, with no post-hoc effort
to retrofit and adjust the values. At the time of a CPI, the
WBC response was considered positive when mean WBC
count was ≥16.0×103cells/µl; mean immature neutrophils
were  ≥10%; or there was an increase in the mean WBC
count by ≥20% relative to the mean count before a CPI. At
the time of a CPI, a positive cholesterol response was
defined as the failure of the mean cholesterol to increase by
more than 10% relative to the mean cholesterol before a CPI.
In other words, cholesterol increased by 10% or less, or it
decreased. A 10% level was selected because this effect
size is commonly used in causal analysis and statistical
assessment of data. The rate of a positive WBC response
and the rate of a positive cholesterol response at the time of
CPI were calculated.
Organ/metabolic dysfunction analysis
PaO2/FiO2, serum bilirubin, serum glucose, serum creatinine,
and serum bicarbonate were assessed for significant relation-
ships with percentage of expected cholesterol.
Statistical analysis
Statistical analysis was performed using the SAS System for
Windows, release 6.11 (SAS Institute Inc., Cary, NC, USA).
Continuous data are represented as the mean and standard
deviation. Paired Student’s t-tests were used to compare
expected cholesterol with immediate postinjury cholesterol
and the mean cholesterol during the SICU stay. A paired Stu-
dent’s t-test was used to compare admission cholesterol with
discharge cholesterol. A Fisher’s exact test was used to
compare the rate of positive cholesterol response with the
rate of positive WBC response during onset of CPIs. Correla-
tion coefficient analysis was utilized to assess the relationship
between two continuous variables. Multiple regression analy-
sis was utilized to assess the influence of two or more inde-
pendent variables on a dependent variable. P<0.05 was
considered statistically significant.
Results
Subject characteristics
Twenty males and eight females met the study criteria. Four
patients had penetrating injuries and twenty-four had sus-
tained blunt injuries. The age was 39.1±13 years, Injury
Severity Score was 30.6±8.6, and CPI per patient was 1.7
(range 0–5). Death occurred in three patients (Table 1).
Surgical intensive care unit hypocholesterolemia
During the entire SICU course, the observed mean choles-
terol for the 28 patients was decreased (132±33mg/dl,
95% confidence interval [CI] 119–145) as compared with
the expected value (201±17mg/dl, 95% CI 194–208;
P<0.0001). This represents a 34.3% reduction. SICU
hypocholesterolemia is described in Fig.1. The percentage of
expected cholesterol was 67±21% (range 20–140%).
Immediate postinjury hypocholesterolemia
The SICU admission (postinjury) cholesterol was decreased
(n=28; 119±44mg/dl, 95% CI 102–136) as compared
with the expected cholesterol (201±17mg/dl, 95% CI
194–208;  P=0.0001). The postinjury cholesterol was
59.4% of the expected cholesterol. Fig.1 demonstrates the
reduction in postinjury cholesterol in two patients.
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Table 1
Subject characteristics and cholesterol values
CPIs during Cholesterol (mg/dl)
SICU stay
Patient Age Male ISS (n) Survived Expected Mean±SD
A 22 No 41 2 Yes 183 134±33
B 33 Yes 42 3 Yes 201 100±25
C 24 No 34 1 No 183 98±12
D 35 Yes 27 2 No 201 187±30
E 45 Yes 10 1 No 211 116±35
F 37 No 16 5 Yes 189 116±20
G 36 Yes 30 2 Yes 201 137±19
H 33 Yes 43 4 Yes 201 93±12
I 38 Yes 35 2 Yes 201 123±19
J 58 Yes 38 4 Yes 216 191±28
K 51 Yes 35 1 Yes 216 97±5
L 61 No 34 1 Yes 235 102±9
M 50 No 26 2 Yes 228 137±15
N 45 Yes 25 2 Yes 211 155±29
O 55 Yes 17 3 Yes 216 133±19
P 40 Yes 19 2 Yes 211 166±14
Q 21 No 36 1 Yes 183 120±40
R 49 Yes 5 0 Yes 211 82±06
S 25 Yes 36 2 Yes 180 195±28
T 38 No 57 1 Yes 189 106±17
U 67 Yes 14 1 Yes 217 118±11
V 24 No 34 2 Yes 183 145±12
W 38 Yes 42 1 Yes 201 192±25
X 43 Yes 24 1 Yes 211 113±27
Y 16 Yes 26 0 Yes 158 131±53
Z 38 Yes 34 0 Yes 201 91±9
AA 43 Yes 35 1 Yes 211 165±39
BB 29 Yes 29 1 Yes 180 153±35
CPI, culture-positive infection; ISS, Injury Severity Score; SD, standard
deviation; SICU, surgical intensive care unit.R148
Comparison of total serum cholesterol at surgical
intensive care unit admission and discharge
For the 25 surviving patients, the cholesterol at SICU dis-
charge was significantly increased (143±35mg/dl) com-
pared with admission cholesterol (112±37mg/dl;
P<0.0001). The SICU discharge value was 27.7% greater
than the admission level. Post-hoc analysis revealed a power
of 97% for means testing. The 95% CI for SICU discharge
cholesterol was 128–157 and for SICU admission it was
97–127. An increase in cholesterol from SICU admission to
discharge is demonstrated in Fig.1. For the three patients
who died, the cholesterol was 117±27mg/dl at SICU dis-
charge and 175±62mg/dl at admission. The SICU dis-
charge value was 33.1% lower than the admission level.
There was a significant difference in the discharge minus
admission cholesterol values between the patients who died
(–58±40mg/dl) and those who survived (31±36mg/dl;
P=0.0005). There was a significant difference in the dis-
charge minus admission percentage of expected cholesterol
values between the patients who died (–29±19%) and
those who survived (16±19%; P=0.0005).
White blood cell and cholesterol responses on days of
culture-positive infection
During the 676 days of SICU care, the WBC count was
16.3±7.1×10 3cells/µl (range 3.9–48.2×103cells/µl),
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Figure 1
The graphs for patients A and B (see Table 1) demonstrate postinjury hypocholesterolemia, persistent hypocholesterolemia with culture-positive
infection, and partial resolution of hypocholesterolemia at discharge from the surgical intensive care unit.
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immature neutrophils comprised 3.3±5.4% (range 0–45%),
and cholesterol was 132±38mg/dl (range 34–248mg/dl).
Forty-eight CPIs occurred during the SICU course: 32 pneu-
monia, four bacteremia, three abdominal abscess/peritonitis,
two central nervous system infections, four vascular catheter
infections, and three severe wound infections. Three patients
were without infection and 25 had one to five infections
(Table 1). Mean cholesterol and WBC count values before
the CPI and at the time of the CPI were computed: choles-
terol 138±39mg/dl and 131±37mg/dl, respectively
(P=0.26); and WBC count 16.3±6.1×103cells/µl and
16.6±7.3×10 3 cells/µl, respectively (P=0.78). In 46 CPIs a
WBC differential was also available; immature neutrophils
comprised 3.9±6.7% and 4.8±7.1% before and at the time
of the CPI, respectively (P=0.38).
Cholesterol data were available for all 48 CPIs. A positive
cholesterol response occurred in 43 (89.6%). Specific cho-
lesterol values at the time of the CPI relative to those before
the CPI were categorized: in five CPIs there was an increase
by >10% (10.4%); in 17 CPIs there was a decrease by
>10% (35.4%); and there was no substantial increase or
decrease in 26 CPIs (54.2%). WBC count data were avail-
able for 47 of the CPIs. Specific WBC counts at the time of
the CPI relative to those before the CPI were noted: in
17 CPIs there was an increase by >10% (36.2%); in
16 CPIs there was a decrease by >10% (34.0%); and there
was no substantial increase or decrease in 14 (29.8%).
Among the 46 CPIs in which WBC count, percentage imma-
ture neutrophils, and cholesterol data were available, the
WBC response was positive in 28 (60.9%) and the choles-
terol response was positive in 42 (91.3%; odds ratio 6.8;
P=0.001). A positive WBC response or positive cholesterol
response was present in 45 out of 46 CPIs (97.8%).
Days of persistent hypocholesterolemia following
onset of culture-positive infections
With the onset of a CPI, the cholesterol value decreased
below the preinfection level over the next 5.1±3.7 days
(range 0–14 days, total days 240). The 240 days accounted
for 35.5% of the total SICU days of observation. The time
required for the cholesterol to improve by more than 10%, rel-
ative to the lowest postinfection value, was 5.0±3.2 days
(total days 237, range 1–14 days). The 237 days accounted
for 35.1% of the total SICU days of observation. Fig.1 shows
the persistent hypocholesterolemia associated with CPI.
Relationships between hypocholesterolemia and
organ/metabolic dysfunction
Significant relationships were found between percentage of
expected cholesterol and organ/metabolic dysfunction (crea-
tinine, bilirubin, bicarbonate, PaO2/FiO2, and glucose), and
these are described in Table 2. The percentage of expected
cholesterol was independently associated with creatinine,
bilirubin, bicarbonate, and PaO2/FiO2 (r=0.32; P=0.001). An
organ/metabolic dysfunction score was computed (creatinine
>2.0mg/dl [score 0 or 1] + bilirubin >2.5mg/dl [0 or 1] +
bicarbonate ≤23 or ≥28mmol/l [0 or 1] + PaO2/FiO2 <350
[0 or 1] + glucose >120mg/dl [0 or 1], yielding a total score
in the range 0–5). Percentage of expected cholesterol pro-
gressively decreased as the number of organ/metabolic dys-
functions increased (n=676; r=–0.30; P=0.0001; Table 3).
The WBC count exhibited a relative increase as the number
of organ/metabolic dysfunctions increased (r=0.17;
P=0.0001). The percentage immature neutrophils increased
as the number of organ/metabolic dysfunctions increased
(r=0.25; P=0.0001). The number of organ/metabolic dys-
functions was independently associated with percentage of
expected cholesterol, WBC count, and percentage immature
neutrophils (r=0.36; P=0.001). Multiple organ failure (MOF)
was defined as the presence of two or more organ/metabolic
dysfunctions. Observations with MOF were associated with a
lower percentage of expected cholesterol (n=482;
64±20%) than were observations without MOF (n=194;
75±20%; P=0.0001).
The organ/metabolic dysfunctions were greater in the
patients who died (n=49; 2.5±0.7) than in those who sur-
vived (n=627; 1.9±1.0; P=0.0001). The rate of MOF was
increased in the patients who died (95.9%) as compared
with the rate in those who survived (69.4%; odds ratio 10.4;
P=0.0001).
Discussion
The present study is the largest description of sequential cho-
lesterol monitoring in critically injured patients. The primary
findings of the study are that hypocholesterolemia is present
following critical injury (marked decrease in SICU admission
cholesterol values compared with expected values); clinical
convalescence is associated with an improvement in hypoc-
holesterolemia (increase in SICU discharge cholesterol
values compared with SICU admission values); patients who
die appear to have a progressive deterioration in serum cho-
lesterol; and cholesterol levels fluctuate during the SICU
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Table 2
Cholesterol values, as a percentage of expected cholesterol,
and organ/metabolic dysfunction relationships
% Cholesterol % Cholesterol
Condition without condition with condition P
Creatinine >2.0mg/dl 68±21 55±13 0.0001
Bilirubin >2.5mg/dl 68±21 60±21 0.0006
Bicarbonate ≥28 or 71±22 63±19 0.0001
≤23mmol/l
PaO2/FiO2 <350 74±21 65±20 0.0001
Glucose >120mg/dl 69±19 65±23 0.009
% Cholesterol is the cholesterol value as a percentage of expected
cholesterol. Values are expressed as mean±standard deviation. FiO2,
fractional inspired oxygen; PaO2, arterial oxygen tension.R150
course. During the SICU course, the percentage of expected
cholesterol varied inversely with organ dysfunction. With the
onset of SICU infections, hypocholesterolemia either worsens
(serum cholesterol decreases) or persists (serum cholesterol
does not increase or decrease). Previous studies have typi-
cally been static in their analysis, relying on single cholesterol
values that do not reflect the dynamics of the daily care and
course of severely injured patients.
Immediately after injury a reduction in cholesterol compared
with expected values was apparent. Expected cholesterol
values were used for comparison because the preinjury
values in the patients studied were not available. The choles-
terol value before trauma in these unselected patients was
considered to be the average value in a general population of
healthy people. The expected cholesterol values were
obtained from age- and sex-based data produced by the
nationally recognized National Health and Nutrition Examina-
tion Surveys [16]. These values have been corroborated in a
survey that included 60502 people throughout North
America [17]. The expected cholesterol levels have also been
validated in a study that included 4600 persons [18]. All of
the patients in the present study had serious injuries, as
demonstrated by the need for mechanical ventilation for
7 days or longer, elevated Injury Severity Scores, a high rate
of CPI, and the notable mortality rate.
Soon after the introduction of a reliable assay for serum cho-
lesterol in 1926, reports associated hypocholesterolemia with
‘disease’ [11]. Lower cholesterol levels were observed during
the acute phase response concomitant with infection, surgi-
cal procedures, burns, and malignancy [10]. After operative
intervention, cholesterol values may decrease by as much as
55% [7]. Although low lipid and lipoprotein levels have clearly
been demonstrated in acutely ill patients, the prognostic
implications of these levels are less well understood [11].
Patients with a new infection typically have a decrease in cho-
lesterol or persistent hypocholesterolemia. A total of 48
serious CPIs were encountered in the 28 patients studied.
Infections were varied and included pneumonia, bacteremia,
abdominal abscess and peritonitis, central nervous system
infection, vascular catheter infection, and deep, serious
wound infections. All infections were associated with sys-
temic and regional manifestations.
A decrease in cholesterol or persistence of hypocholes-
terolemia was more commonly associated with the develop-
ment of a CPI than with the expected leukocyte response.
The WBC count and differential at the time of infection did
not consistently increase or decrease. Although most clini-
cians consider an increment in WBC or left-shift to be associ-
ated with the presence of infection, a positive WBC response
was present in a much smaller percentage of CPIs in compar-
ison with the higher percentage of CPIs with a positive cho-
lesterol response. Virtually all CPIs had a positive WBC
and/or cholesterol response. Cholesterol values remained
below the preinfection values for nearly 1 week and
accounted for one-third of total SICU days. Cholesterol
values required almost 1 week to increase substantially rela-
tive to the post-CPI nadir level. These data suggest that per-
sistent or progressive hypocholesterolemia may be a more
sensitive indicator of the onset of infection than is WBC
response.
Cioffi and coworkers [19] reviewed the complex array of
leukocyte responses following injury. Changes in leukocyte
number and function can be associated with infection, sepsis,
or the initial injury. Toutouzas and coworkers [20] docu-
mented the difficulty in discerning whether leukocytosis is
associated with the injury per se or with infectious complica-
tions in patients undergoing postinjury splenectomy. Rovlias
and Kotsou [21], in a recent report, indicated that leukocyto-
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Table 3
Organ/metabolic dysfunction score relationships with cholesterol, as a percentage of expected cholesterol, white blood cell count,
and percentage immature neutrophil values
% WBC WBC
as immature % (× 103 % Immature
Score Observations neutrophils Cholesterol* cells/µl) neutrophils
0 60 8.9 81±15 16.4±7.3 1.4±2.6
1 134 19.8 72±21 15.1±6.4 2.5±5.4
2 281 41.6 67±21 15.2±6.3 2.8±4.4
3 167 24.7 62±20 17.8±7.9 4.4±6.0
4 33 4.9 51±14 21.6±8.0 9.3±9.0
5 1 0.1 54±0.0 32.9±0.0 5.0±0.0
P = 0.0001 P = 0.0001 P = 0.0001
*Percent cholesterol is the observed value as a percentage of the expected value. Values are mean and standard deviation.R151
sis is common in patients with severe brain injury. The find-
ings in these reports support the notion that WBC responses
are not predictive of infection.
In one ICU based study, Gordon and coworkers [10] noted
that patients with clinical and/or laboratory evidence of infec-
tion had significantly lower mean high-density lipoprotein cho-
lesterol concentrations. In another study of 111 critically ill
patients, Gordon and coworkers [11] demonstrated a rela-
tionship between the degree of inflammation and the extent of
hypocholesterolemia. Studies conducted both in humans and
in nonhuman primates demonstrate an association between
hypocholesterolemia and the release of endotoxin and
cytokine mediators during sepsis [7]. When cholesterol
values do not increase, the clinician should suspect possible
infection in critically injured or ill patients.
Typically, organ/metabolic dysfunction scores reflect the
degree of patient illness severity. In the present study,
organ/metabolic dysfunction scores were derived from an
evaluation of daily bicarbonate, bilirubin, creatinine, glucose,
and PaO2/FiO2. The Acute Physiology and Chronic Health
Evaluation III score [22], Simplified Acute Physiology Score
[23], Multiple Organ Dysfunction Score [24], and Sequential
Organ Failure Assessment Score [25] are recognized illness
severity scoring systems and include variables that are similar
to the five system components used in the present study:
PaO2/FiO2 [22–25], acid–base balance [22,23], bilirubin
[22–25], glucose [22], and creatinine [22,24,25]. The trauma
patient MOFs described by Cryer and coworkers [26] and by
Dunham and colleagues [27] also include the system compo-
nents used in the present study: PaO2/FiO2 [26,27],
acid–base balance [27], bilirubin [26], glucose [27], and cre-
atinine [26,27]. Patients who died had a higher organ/meta-
bolic score and rate of MOF than did the survivors. This
further suggests the clinical relevance of the methodology
used to describe organ/metabolic dysfunction in the present
study.
Two other investigations have documented an association
between hypocholesterolemia and organ failure [4,11]. Of rel-
evance is that researchers have found cholesterol to be
decreased in critically ill surgical patients with decreased
hepatic protein synthesis [5]. Additionally, cholesterol during
the first week after injury has been inversely associated with
the number of ventilator days and hospital duration of stay
[1]. These findings are consonant with our study findings that
cholesterol is inversely related to organ dysfunction.
In the present study, the percentage of expected cholesterol
values was inversely associated with the five organ/metabolic
dysfunctions as well as with the derived score values. The
number of organ/metabolic dysfunctions was also related to
the WBC count and percentage of immature neutrophils.
However, the correlation was greater with the percentage of
expected cholesterol. These observations support the notion
that organ/metabolic dysfunction described in the study is
related to systemic inflammation. The independent relation-
ship between organ/metabolic dysfunction and percentage of
expected cholesterol, WBC count, and percentage immature
neutrophils is also consistent with the thesis that cholesterol
levels indicate that other inflammatory signals may be inciting
homeostatic perturbations. The patients with MOF had a sig-
nificantly lower percentage of expected cholesterol values
than did those without MOF. These findings suggest that
changes in hypocholesterolemia mirror the clinical course of
critically injured patients.
Hypocholesterolemia was improved in the convalescing
patients. In the survivors the cholesterol values at SICU dis-
charge were significantly increased as compared with the
admission values. Although the number of patients studied
was relatively small, the power of the test was well within the
range for difference of means testing in related samples. Fur-
thermore, the lack of overlap between the 95% upper limit
for the admission value and the 95% lower limit for the dis-
charge value enhances the validity that the means of the two
groups are different. In the three patients who died the cho-
lesterol levels at the time of death were decreased com-
pared with their SICU admission levels. However, the
number of patients is too small for this observation to be
conclusive. Gordon and coworkers [10] described
decreased cholesterol values in patients requiring transfer to
the SICU. Giovannini and coworkers [5] also found an
increased frequency of hypocholesterolemia among patients
with moderate to critical surgical illness requiring admission
to the SICU. In summary, the present study indicates that
cholesterol levels typically increase as patients convalesce
and approach discharge from the SICU. On the other hand,
patients who die appear to have a progressive decrement in
cholesterol values.
There are study weaknesses that should be considered in
future investigations. Fluid administration and dilution were
not assessed for their impact on cholesterol levels. The
amounts and types of lipid administered to the study patients
may have been variable and might have influenced choles-
terol values. However, routine enteral and parenteral nutri-
tional support protocols were used in all patients. None of the
patients received propofol. Total serum cholesterol values
were performed each morning. Because no study patient was
from an interhospital transfer, the times from injury to admis-
sion were similar. However, the time from injury to the follow-
ing morning might have varied. The impact of this variation on
cholesterol values was not considered. Future studies should
consider the influence of the volume of fluid, and the amounts
and types of lipids administered each day on serum choles-
terol. Also, investigators may need to obtain cholesterol
values at precise intervals relative to the time of injury. A study
that includes a larger number of dying patients is necessary
to determine whether patients who die have progressive
hypocholesterolemia.
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Conclusion
This study is unique in that serum cholesterol values were
sequentially monitored in critically injured patients during their
SICU course. The convalescing, critically injured patients had
a significant increment in cholesterol levels compared with
the hypocholesterolemia that was observed initially following
severe trauma. Patients who die appear to have a progressive
decrement in serum cholesterol. A decrease in serum choles-
terol or persistent hypocholesterolemia also suggests the
onset of a new, serious infection. In contrast, WBC
responses were less consistent and less sensitive in predict-
ing the onset of infection. A decrement in cholesterol also
indicates a progression in organ failure. Conversely, an
increase in cholesterol suggests that organ failure is resolv-
ing. These data support the notion that serial serum choles-
terol values parallel clinical improvement or deterioration in
critically ill trauma patients. Future studies may prove that
sequential cholesterol monitoring during the SICU course of
critically injured patients will lead to more timely interventions
and enhance patient outcomes.
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